IPO - Marygold Companies, Inc.

Form Type: 424B5

Filing Date: 2025-03-07

Corporate Action: Ipo

Type: New

Accession Number: 000149315225009595

Filing Summary: Marygold Companies, Inc. is offering up to $4,650,000 of its common stock through an Equity Distribution Agreement with Maxim Group LLC. The shares will be sold 'at-the-market' prices, with a minimum sales price of $1.50 per share until May 28, 2025, and Maxim will act as the sales agent. The company intends to use the proceeds for debt reduction, investments in financial services, and other corporate purposes. The common stock is listed on the NYSE American under the symbol 'MGLD.' As of February 28, 2025, the market value of the shares held by non-affiliates was approximately $20.7 million. Historically, the company has sold $2,255,000 in securities over the past 12 months. The prospectus supplement highlights recent developments, including previous equity financing on January 28, 2025, where 2,050,000 shares were sold at $1.10 each, and a note financing agreement indicating a focus on managing and optimizing their financial needs.

Document Link: View Document

Form Type: 424B5

Filing Date: 2025-01-27

Corporate Action: Ipo

Type: New

Accession Number: 000149315225003788

Filing Summary: The Marygold Companies, Inc. is offering 2,050,000 shares of its common stock at a price of $1.10 per share. The offering follows SEC regulations and is part of a shelf registration statement filed on Form S-3. The company is classified as a smaller reporting company and will comply with reduced reporting requirements. As of December 20, 2024, the public float was approximately $18 million, and the closing price prior to the offering was $1.57 per share. In 12 months preceding the offering date, the company has not sold any shares under the registration statement. The underwriters have a 45-day option to purchase an additional 307,500 shares. Expected net proceeds are approximately $1.85 million, earmarked for debt reduction and working capital. The shares are listed on NYSE American under the symbol 'MGLD.'

Document Link: View Document

Form Type: 8-K

Filing Date: 2025-01-27

Corporate Action: Ipo

Type: New

Accession Number: 000149315225003789

Filing Summary: On January 26, 2025, The Marygold Companies, Inc. entered into an underwriting agreement with Maxim Group LLC for an initial public offering (IPO) of 2,050,000 shares of its common stock at a public offering price of $1.10 per share. The underwriter is granted a 45-day option to purchase an additional 307,500 shares. The company estimates net proceeds of approximately $1,850,000, intended to be used for debt retirement, capital contributions to subsidiaries, and general corporate purposes. The offering, registered under a shelf registration statement, is anticipated to close around January 28, 2025, subject to standard closing conditions. Press releases announcing the launch and pricing of the offering were issued by the company on January 24 and January 26, 2025, respectively.

Document Link: View Document

Form Type: 424B5

Filing Date: 2025-01-24

Corporate Action: Ipo

Type: New

Accession Number: 000149315225003567

Filing Summary: The Marygold Companies, Inc. is offering common stock under a preliminary prospectus supplement filed on January 24, 2025. The offering consists of a number of shares at an unspecified price per share, with the last reported sale price of $1.65 prior to this date. The company is presenting this offering under registration number 333-283898, which was declared effective by the SEC on December 27, 2024. The company is categorized as a smaller reporting company and will adhere to reduced reporting requirements. This offering is part of their plan to raise capital, which they may use to pay down debt and invest in their subsidiaries. The company emphasizes the inherent risks in investing, cautioning potential investors regarding market conditions and operational uncertainties that could affect financial performance. Additionally, the risks associated with their recent note financing transaction and associated covenants were described, highlighting implications for their operational flexibility.

Document Link: View Document